Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

BACKGROUND: COVID-19 threatens to quickly overwhelm our existing critical care infrastructure in the USA. Systemic tissue plasminogen activator (tPA) has been previously demonstrated to improve PaO2/FiO2 (mmHg) when given to critically ill patients with acute respiratory distress syndrome (ARDS). It...

Full description

Bibliographic Details
Main Authors: Choudhury, Rashikh, Barrett, Christopher D., Moore, Hunter B., Moore, Ernest E., McIntyre, Robert C., Moore, Peter K., Talmor, Daniel S., Nydam, Trevor L., Yaffe, Michael B.
Other Authors: Koch Institute for Integrative Cancer Research at MIT
Format: Article
Published: Springer Science and Business Media LLC 2020
Subjects:
Surgery
Emergency Medicine
Online Access:https://hdl.handle.net/1721.1/124896

Internet

https://hdl.handle.net/1721.1/124896

Similar Items